Shedir Pharma Group
Researches, develops, and commercializes health and wellness products.
SHE | XMIL
Overview
Corporate Details
- ISIN(s):
- IT0005379620
- LEI:
- 81560092B300849E9017
- Country:
- Italy
- Address:
- VIA BAGNULO, 95, 80063 PIANO DI SORRENTO
- Sector:
- Manufacturing
Description
Shedir Pharma Group specializes in the research, development, formulation, and commercialization of health and wellness products. The company's portfolio encompasses nutraceuticals, dermocosmetics, medical devices, and pharmaceuticals. A key focus is on innovation, resulting in the creation of unique and patented product formulations that cover approximately 15 therapeutic areas. The group operates through specialized subsidiaries that manage the entire product lifecycle, from initial research and intellectual property to marketing and distribution. Products are offered in various forms, such as capsules, tablets, powders, liquids, and gels, targeting professionals in the medical and pharmaceutical sectors.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2019-10-15 18:15 |
Ottenimento 3 brevetti Italiani Peaflosin, Senydem e Peamotix
|
Italian | 375.8 KB | ||
| 2019-10-02 17:47 |
Comunicazione pubblicazione del nuovo statuto sociale
|
Italian | 309.7 KB | ||
| 2019-10-01 17:56 |
Comunicazione variazione capitale sociale
|
Italian | 306.5 KB | ||
| 2019-09-30 19:23 |
Approvata la Relazione Consolidata Semestrale 2019
|
Italian | 495.6 KB | ||
| 2019-09-05 07:31 |
Ottenimento brevetto italiano Zexin
|
Italian | 79.4 KB | ||
| 2019-08-22 23:25 |
Parziale esercizio dell’opzione Greenshoe
|
Italian | 80.7 KB | ||
| 2019-08-22 07:47 |
Comunicazione chiusura periodo di stabilizzazione
|
Italian | 108.8 KB | ||
| 2019-08-22 07:41 |
Comunicazione intermedia durante il periodo di stabilizzazione
|
Italian | 135.2 KB | ||
| 2019-08-09 23:55 |
Comunicazione intermedia durante il periodo di stabilizzazione
|
Italian | 108.0 KB | ||
| 2019-08-01 07:30 |
Ottenimento brevetto europeo Wellflu®
|
Italian | 83.6 KB | ||
| 2019-08-01 07:30 |
European Wellflu® patent awarded
|
English | 84.2 KB | ||
| 2019-07-30 23:40 |
Comunicazione intermedia durante il periodo di stabilizzazione
|
Italian | 158.2 KB | ||
| 2019-07-29 07:40 |
H1 2019 Revenues grow by 10%
|
English | 90.1 KB | ||
| 2019-07-29 07:30 |
Ricavi primo semestre 2019 in crescita del 10%
|
Italian | 88.5 KB | ||
| 2019-07-26 07:31 |
Italian patent obtained for Slowpil
|
English | 84.4 KB |
Automate Your Workflow. Get a real-time feed of all Shedir Pharma Group filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Shedir Pharma Group
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Shedir Pharma Group via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
